Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges
Advanced Science · 22.06.2026
DOI: 10.1002/advs.76169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 22.06.2026. Verfasst von Madiha Habib und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Fund, Research Impact Fund, Health and Medical Research Fund.
Abstract (Originalsprache)
Allergic disorders, including food allergy, asthma, and atopic dermatitis, affect an estimated 10–30% of the global population, with prevalence continuing to rise in industrialized countries. Allergy is driven by dysregulated type 2 T‐helper cells (Th2) and immunoglobulin E (IgE) antibody responses. A range of diagnostic tools is available, but most methods are limited by variable sensitivity and specificity, and the inability to predict clinical reactivity. Although allergen‐specific immunotherapy (AIT) remains the only etiological therapeutic method for allergic disorders, conventional AITs are limited by frequent administration, risk of adverse events, suboptimal patient adherence, and inconsistent long‐term efficacy. Advances in nanotechnology offer emerging opportunities for improving allergy diagnosis and treatment through enhanced analytical sensitivity, targeted allergen delivery and controlled immune modulation. This review provides a comprehensive overview of the latest research on nanomaterials, including their application in nanomaterials‐based diagnostic systems and nano‐enabled immunotherapies. We highlight their roles in improving allergen‐specific IgE detection, refining functional cellular assays, and enabling next‐generation immunotherapies through controlled allergen delivery and immunomodulation. We also critically examine key translational barriers and outline essential future directions required for translating nanotechnologies into clinical practice in allergy medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
- Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, California, USA.
- Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Ting F Leung, Christine Yy Wai
Förderung
- General Research Fund
- Research Impact Fund
- Health and Medical Research Fund
- National Natural Science Foundation of China
- Research Committee Postdoctoral Fellowship Scheme
Zitieren
APA
Habib, M., Jiang, S., Lee, J. Z., Lim, C. W., Yeung, H. L., Leung, N. Y., Leung, P. S., Leung, T. F., & Wai, C. Y. (2026). Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges. Advanced Science. https://doi.org/10.1002/advs.76169
Vancouver
Habib M, Jiang S, Lee JZ, Lim CW, Yeung HL, Leung NY, et al. Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges. Advanced Science. 2026. doi:10.1002/advs.76169
BibTeX
@article{Habib2026,
author = {Habib, Madiha and Jiang, Shan and Lee, Joyce Zx and Lim, C W and Yeung, H L and Leung, Nicki Yh and Leung, Patrick Sc and Leung, Ting F and Wai, Christine Yy},
title = {Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76169}
}
EUVIMED